732 studies found for:    "Esophageal Neoplasms"
Show Display Options
Rank Status Study
1 Completed Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Cancer of the Esophagus;   Esophagus Cancer;   Esophageal Neoplasm;   Cancer of Esophagus
Interventions: Drug: Irinotecan (drug);   Drug: Taxotere (drug);   Procedure: Radiotherapy (procedure);   Procedure: Esophagectomy (procedure)
2 Recruiting Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
Conditions: Esophageal Neoplasm;   Esophageal Cancer TNM Staging Primary Tumor (T) T2;   Esophageal Cancer TNM Staging Primary Tumor (T) T3;   Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0;   Esophageal Cancer TNM Staging Distal Metastasis (M) M0
Intervention: Radiation: Prophylactic postoperative radiation therapy
3 Active, not recruiting Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Capecitabine (Xeloda)
4 Terminated Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: CD40 Ligand Gene (AdcuCD40L)
5 Completed
Has Results
Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial
Condition: Esophageal Neoplasm
Interventions: Other: Restrictive group;   Other: Liberal group
6 Terminated Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: AdcuCD40L
7 Completed Outcomes After Esophageal Cancer Surgery
Conditions: Esophageal Neoplasm;   Esophageal Disease
Intervention: Procedure: Esophagectomy
8 Terminated Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
Conditions: Esophageal Neoplasms;   Carcinoma, Squamous Cell;   Adenocarcinoma;   Esophageal Cancer
Interventions: Drug: Capecitabine (Xeloda);   Drug: [18-F] Fluorodeoxyglucose (FDG);   Drug: 5-Fluorouracil (5-FU);   Drug: Carboplatin
9 Unknown  Docetaxel and S-1 for Advanced Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: DS (docetaxel+S-1)
10 Terminated Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
Conditions: Barrett Esophagus;   Esophageal Neoplasms;   Deglutition Disorders;   GERD;   Neoplasm
Interventions: Device: CSA System (CryoSpray AblationTM System);   Device: CryoSpray Ablation
11 Terminated A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Procedure: Esophagectomy
12 Completed Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Recurrent Esophageal Cancer;   Squamous Cell Carcinoma of the Esophagus;   Stage III Esophageal Cancer;   Stage IV Esophageal Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
13 Recruiting Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
Condition: Esophageal Neoplasms
Interventions: Other: Preoperative treatment of chemotherapy and radiation;   Other: Postoperative treatment of chemotherapy and radiation
14 Unknown  PET-CT Based Radiotherapy in Esophageal Cancer Patients
Condition: Esophageal Neoplasms
15 Active, not recruiting Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Adenocarcinoma of the Stomach;   Squamous Cell Carcinoma of the Esophagus;   Stage II Esophageal Cancer;   Stage II Gastric Cancer;   Stage III Esophageal Cancer;   Stage III Gastric Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: oxaliplatin;   Drug: fluorouracil;   Radiation: radiation therapy;   Procedure: conventional surgery;   Other: immunohistochemistry staining method;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: laboratory biomarker analysis;   Genetic: gene expression analysis;   Radiation: fludeoxyglucose F 18
16 Withdrawn Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy
Condition: Esophageal Carcinoma
Intervention: Drug: Bevacizumab, cetuximab
17 Recruiting Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer
Conditions: Surgical Procedures;   Minimally Invasive;   Operative;   Esophageal Neoplasms;   Cancer of Esophagus;   Esophagectomy
Interventions: Procedure: Ivor Lewis;   Procedure: Tri-incision
18 Recruiting Comparable Study of Different Radiation Dose in Esophageal Carcinoma
Condition: Esophageal Carcinoma
Interventions: Radiation: intensity modulated radiation therapy in both arms;   Drug: concurrent chemotherapy with radiation
19 Recruiting Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma
Condition: Esophageal Carcinoma
Intervention: Drug: Pertuzumab, trastuzumab
20 Completed Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan.
Condition: Esophageal Carcinoma
Interventions: Drug: Cisplatin;   Drug: Irinotecan;   Radiation: External Beam Radiation Therapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years